Immutep Limited Gains 164.65%
Thu, Dec 10, 2020 at 05:30 PM
Immutep Limited (IMMP:NASDAQ) shot up at $5.69, a gain of 164.7%. On Wed 09 Dec 20, IMMP:NASDAQ touched a New 2-Week High of $2.15. The stock got featured on our News Catalysts scanner on Thu 10 Dec 20 at 02:38 PM in the 'BIOTECH' category. From Wed 25 Nov 20, the stock recorded 55.56% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Immutep Limited (IMMP:NASDAQ)
Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.
Top 10 Gainers:
- SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 176.37%
- Immutep Limited (IMMP:NASDAQ), 164.65%
- Veru Inc. (VERU:NASDAQ), 53.47%
- Sangamo Therapeutics, Inc. (SGMO:NASDAQ), 52.98%
- Neos Therapeutics, Inc. (NEOS:NASDAQ), 47.7%
- TG Therapeutics, Inc. (TGTX:NASDAQ), 40.85%
- Arlington Asset Investment Corp. (AI:NYSE), 40.56%
- Peabody Energy Corporation (BTU:NYSE), 37.84%
- ALXO (ALXO:NASDAQ), 37.35%
- Silver Spike Acquisition Corp. (SSPK:NASDAQ), 37.27%